Advertisement
Canada markets open in 2 hours 45 minutes
  • S&P/TSX

    21,714.54
    -297.08 (-1.35%)
     
  • S&P 500

    5,035.69
    -80.48 (-1.57%)
     
  • DOW

    37,815.92
    -570.17 (-1.49%)
     
  • CAD/USD

    0.7261
    -0.0000 (-0.01%)
     
  • CRUDE OIL

    80.83
    -1.10 (-1.34%)
     
  • Bitcoin CAD

    79,340.19
    -5,616.70 (-6.61%)
     
  • CMC Crypto 200

    1,235.77
    -103.30 (-7.72%)
     
  • GOLD FUTURES

    2,301.20
    -1.70 (-0.07%)
     
  • RUSSELL 2000

    1,973.91
    -42.12 (-2.09%)
     
  • 10-Yr Bond

    4.6860
    +0.0720 (+1.56%)
     
  • NASDAQ futures

    17,420.75
    -150.50 (-0.86%)
     
  • VOLATILITY

    16.08
    +0.43 (+2.75%)
     
  • FTSE

    8,151.90
    +7.77 (+0.10%)
     
  • NIKKEI 225

    38,274.05
    -131.61 (-0.34%)
     
  • CAD/EUR

    0.6801
    -0.0001 (-0.01%)
     

This Vaccine Maker Sits on Cash Almost Equal to Its Market Value

This Vaccine Maker Sits on Cash Almost Equal to Its Market Value

This biotechnology company has nearly 90% of its market value in cash and investments but is being shunned by investors even as they gravitate to the sector this year. The company is BioNTech (Ticker BNTX). It partnered with Pfizer to produce the leading Covid vaccine, Comirnaty, whose original messenger RNA technology was developed by BioNTech.